Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56brightCD16− natural killer cells.

Autor:	Haque Chowdhury, Helena1,2 (AUTHOR), Hawlina, Simon3,4 (AUTHOR), Gabrijel, Mateja1,2 (AUTHOR), Trkov Bobnar, Saša1,2 (AUTHOR), Kreft, Marko1,2,5 (AUTHOR), Lenart, Gordan3 (AUTHOR), Cukjati, Marko6 (AUTHOR), Kopitar, Andreja Nataša7 (AUTHOR), Kejžar, Nataša8 (AUTHOR), Ihan, Alojz7 (AUTHOR), Ležaič, Luka9,10 (AUTHOR), Grmek, Marko9 (AUTHOR), Kmetec, Andrej3 (AUTHOR), Jeras, Matjaž1,11 (AUTHOR), Zorec, Robert1,2 (AUTHOR) robert.zorec@mf.uni-lj.si
Zdroj:	Clinical & Translational Medicine. Aug2021, Vol. 11 Issue 8, p1-7. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu